Site of ATP and phenylephrine synergistic stimulation of vasopressin release from the hypothalamo-neurohypophyseal system.
ATP and norepinephrine are neurotransmitters carrying cardiovascular information to vasopressin (AVP) neurones. As shown previously, exposure of hypothalamo-neurohypophyseal system explants to ATP and phenylephrine (PE) (alpha(1)-adrenergic agonist) causes a significantly larger increase in AVP release than with either agent alone and converts the response from a transient to a sustained stimulation of AVP release. Potential mechanisms for this synergism include presynaptic stimulation of excitatory afferent input (i.e. glutamate release), postsynaptic activation of receptors on AVP neurones, modulation of stimulus-secretion coupling in the neural lobe and/or involvement of glial/neuronal interactions. The response to ATP + PE (100 microM each) was not altered in the presence of either a cocktail of ionotropic glutamate receptor antagonists (CNQX + AP5) or a nonselective metabotropic glutamate receptor antagonist [(RS)-alpha-methyl-4-carboxyphenylglycine]. Thus, it is not dependent on activation of glutamate receptors. Treatment with tetrodotoxin (3 microM) eliminated the response to ATP + PE. Because this could reflect blockade of action potentials propagated from the AVP perikarya to the nerve terminals in the neural lobe or action potentials generated in the neural lobe directly, synergism in the neural lobe was addressed by perifusing isolated neural lobes with ATP and PE alone or together. Synergistic stimulation of AVP release by ATP + PE was not observed in isolated, perifused neural lobes. Thus, the synergistic effect persists in the absence of glutamate transmission, is not due to synergistic actions of P(2) and alpha(1)-adrenergic receptors occurring at the level of the neural lobe and requires action potentials in either the hypothalamus or neural lobe.
Song
Z
Z
Department of Physiology and Biophysics, University of Colorado at Denver and Health Sciences Center, Aurora, 80045, USA. zhilin.song@uchsc.edu
Sladek
C D
CD
D000255:Adenosine Triphosphate / Q000494:pharmacology / Q000502:physiology*; D000316:Adrenergic alpha-Agonists / Q000494:pharmacology; D000818:Animals; D001127:Arginine Vasopressin / Q000378:metabolism*; D004357:Drug Synergism; D007030:Hypothalamo-Hypophyseal System / Q000187:drug effects / Q000378:metabolism*; D008297:Male; D009434:Neural Pathways / Q000187:drug effects / Q000378:metabolism*; D009924:Organ Culture Techniques; D010656:Phenylephrine / Q000494:pharmacology*; D010904:Pituitary Gland, Posterior / Q000187:drug effects / Q000378:metabolism; D051381:Rats; D017207:Rats, Sprague-Dawley; D018709:Statistics, Nonparametric
D000316:Adrenergic alpha-Agonists; D001127:Arginine Vasopressin; D010656:Phenylephrine; D000255:Adenosine Triphosphate